MiR-302b Regulates Cell Functions and Acts As a Potential Biomarker to Predict Recurrence in Bladder Cancer

Zuwei Li,Liang Zhou,Canbin Lin,Xiang Pan,Jiansen Xie,Liwen Zhao,Jing Quan,Jinling Xu,Xin Guan,Weijie Xu,Hang Li,Yun Chen,Yongqing Lai
DOI: https://doi.org/10.1016/j.lfs.2018.07.057
IF: 6.78
2018-01-01
Life Sciences
Abstract:Background: Bladder cancer is the most common urogenital tumor with substantial morbidity, high recurrence rate and mortality. miRNAs, a class of endogenous noncoding RNA, were found to involve in the genesis, maintenance and metastasis of cancer. Genomic profiling revealed that miR-302b is down-regulated in bladder cancer while its functions in bladder cancer remain to be ascertained. Methods: Cell functional assays including wound healing assay, CCK-8 assay, Transwell assay and flow cytometry assay were performed to clarify the functions of miR-302b expression in cell proliferation, migration, invasion and apoptosis in BC. Furthermore, RT-qPCR was performed to study the expression of miR-302b in bladder cancer tissues and the prognostic value of altered miR-302b expression with 48 formalin-fixed paraffin-embedded bladder urothelial carcinoma samples. Results: The results of RT-qPCR demonstrated that expression level of miR-302b was significantly reduced in bladder cancer tissues and cell lines. The cells after transfected with miR-302b mimic showed lower mobility, lower proliferation and increased apoptosis, while opposite results were obtained after inhibiting the expression of miR-302b. The prognosis analysis demonstrated that the patients with low expression of miR-302b experienced high risks of recurrence. Conclusions: The results of our study demonstrate that miR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer.
What problem does this paper attempt to address?